Of note, most patients included in this study were relatively healthy, with an eGFR of at least 45 mL/min/1.73 m2; no history of ischemic heart disease or heart failure; and not taking metformin, insulin, SGLT2is, ACEis, or ARBs. This evidence concerns the gene INS and coronary artery disorder.